Navigation Links
Testosterone Therapy can improve sexual function in postmenopausal women

The addition of testosterone to hormone therapy in women after menopause has been found to enhance their sexual performance. However, it may also reduce HDL cholesterol (the “good” cholesterol) in women, according to a recent research.//

Menopause generally begins around age 40, and is characterized by decreased levels of the female sex hormones- estrogen and progesterone that preserve intactness of the vagina and uterus. In addition the hormone is also involved in the health of bones and keeping HDL at healthy levels. Changes brought by menopause can lead to side effects such as “hot flashes” and problems with mood, sleep, memory and joint stiffness.

Sexual function is also compromised in many women. The genital area can become dry and thin during or after menopause, making sexual intercourse painful and undesirable. There is an accompanying decrease in the sex drive (libido), reflected by slower sexual response in some women.

Testosterone is a natural sex hormone produced by the testis. Although it is thought of as a male hormone, women secrete small amounts of it as well. The present study involved the examination of over 1,957 patients who were given testosterone in addition to the conventional hormone replacement therapy for 6 months. The participants were required to fill questionnaires reflecting their sexual activity, libido and side effects if any.

The observed benefits and side effects included a sense of well-being, unexplained fatigue, breast cancer, mood changes, acne and increased hair growth; none were significant enough to be linked definitively to the addition of testosterone to hormone replacement therapy. If the reduction in HDL had been associated with an increase in triglycerides [fatty acids] or LDL cholesterol it would be of great concern. Testosterone has not been found to alter other coronary heart disease risk factors. The researchers have however expressed concern for potential side effects with long term testosterone usage such as voice changes, increased body and facial hair, acne and other undesirable defeminizing side-effects.

The authors do caution that adding testosterone to HT is not a panacea for sexual dysfunction in women and that a comprehensive approach is recommended. “Because of the complex nature of female sexual dysfunction it is often difficult to establish the meaningful steps in treatment,” they write. “Treatment options for sexual dysfunction include identification of correctable causes, education and counseling, and medical therpy.”
'"/>




Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Low Testosterone Levels the Cause Of Depression In Men
3. The Use Of Testosterone Replacement Therapy Questioned
4. Depression In Men Could Be To Low Testosterone Levels
5. Testosterone patch for women Rejected For safety Reasons
6. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
7. Fatherhood Found To Tame Men by Reducing Testosterone Levels
8. Testosterone levels could serve as a marker for determining risk of SIDS
9. Males Lifespan Shortened By Elevated Levels Of Testosterone
10. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
11. Low Testosterone Linked With Early Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance ... a medical-grade battery-powered display stand specifically designed for endoscopy environments. An ... technology into a clinical solution to support the improvement of patient ... Innovative Design ... Wireless Solution ...
(Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
Breaking Medicine Technology: